Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 6/20 | 0.45 |
| ▸ | PARP1 | P09874 | 1/20 | 0.40 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.40 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.40 |
| ▸ | FABP4 | P15090 | 2/20 | 0.38 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
| ▸ | DAO | P14920 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12491707 | 0.93 | DHODH (0.41) | DHODHPARP1PARP15PARP10FABP4 | |
| SCHEMBL217840 | 0.93 | DHODH (0.41) | DHODHPARP1PARP15PARP10FABP4 | |
| SCHEMBL5415654 | 0.93 | DHODH (0.41) | DHODHPARP1PARP15PARP10FABP4 | |
| SCHEMBL17024327 | 0.93 | DHODH (0.41) | DHODHPARP1PARP15PARP10FABP4 | |
| SCHEMBL17024326 | 0.93 | DHODH (0.41) | DHODHPARP1PARP15PARP10FABP4 | |
| SCHEMBL28247062 | 0.93 | DHODH (0.41) | DHODHPARP1PARP15PARP10FABP4 | |
| SCHEMBL12491709 | 0.93 | DHODH (0.41) | DHODHPARP1PARP15PARP10FABP4 | |
| Bromide SCHEMBL689744 | 0.90 | DHODH (0.39) | DHODHPARP1PARP15PARP10FABP4 | |
| SCHEMBL6740335 | 0.90 | DHODH (0.39) | DHODHPARP1PARP15PARP10FABP4 | |
| Hydrochloric Acid SCHEMBL3670412 | 0.90 | DHODH (0.39) | DHODHPARP1PARP15PARP10FABP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 661 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025215126-A1 | SYNTHESIS OF VIDOFLUDIMUS AND ITS CALCIUM SALT | IMMUNIC AG (DE) | 2025-10-16 | — | — | WO | claimed |
| EP-4326247-A1 | CITRACONIC ACID AND DERIVATIVES THEREOF FOR USE AS A MEDICAMENT | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2024-02-28 | — | — | EP | claimed |
| CN-117202901-A | Use of citraconic acid and its derivatives as medicaments | 亥姆霍兹感染研究中心有限公司 | 2023-12-08 | — | — | CN | claimed |
| WO-2022223778-A1 | CITRACONIC ACID AND DERIVATIVES THEREOF FOR USE AS A MEDICAMENT | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2022-10-27 | — | — | WO | claimed |
| US-8822132-B2 | Colored dispersion, photoresist composition and black matrix | LG CHEM, LTD. (KR) | 2014-09-02 | — | — | US | claimed |
| US-20140031289-A1 | POLY(ORGANOPHOSPHAZENE) CONTAINING DEGRADATION CONTROLLABLE IONIC GROUP, PREPARATION METHOD THEREOF AND USE THEREOF | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2014-01-30 | — | — | US | claimed |
| EP-1597632-B1 | NON-MAGNETIC MONOCOMPONENT POSITIVE TONER COMPOSITION HAVING SUPERIOR TRANSFER EFFICIENCY | LG CHEMICAL LTD (KR) | 2013-03-27 | — | — | EP | claimed |
| US-20100104981-A1 | COLORED DISPERSION, PHOTORESIST COMPOSITION AND BLACK MATRIX | LG CHEM, LTD. (KR) | 2010-04-29 | — | — | US | claimed |
| EP-1597632-A4 | NON-MAGNETIC MONOCOMPONENT POSITIVE TONER COMPOSITION HAVING SUPERIOR TRANSFER EFFICIENCY | LG CHEMICAL LTD (KR) | 2009-08-26 | — | — | EP | claimed |
| WO-2009061159-A2 | COLORED DISPERSION, PHOTORESIST COMPOSITION AND BLACK MATRIX | LG CHEM. LTD. (KR) | 2009-05-14 | — | — | WO | claimed |
| US-20060258796-A1 | Crosslinked polyethylene compositions | GENERAL ELECTRIC COMPANY | 2006-11-16 | — | — | US | claimed |
| WO-2006113110-A1 | PROCESS FOR MAKING A THERMOPLASTIC VULCANIZATE COMPOSITION | GENERAL ELECTRIC COMPANY (US) | 2006-10-26 | — | — | WO | claimed |
| WO-2006113180-A1 | SILYLATED THERMOPLASTIC VULCANIZATE COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2006-10-26 | — | — | WO | claimed |
| US-20060229399-A1 | Process for making a thermoplastic vulcanizate composition | GENERAL ELECTRIC COMPANY | 2006-10-12 | — | — | US | claimed |
| EP-1698678-A1 | HEAT CARRIER COMPOSITION | Shishiai-Kabushikigaisha (JP) | 2006-09-06 | — | — | EP | claimed |
| US-20060105260-A1 | Non-magnetic monocomponent positive toner composition having superior transfer efficiency | LG CHEM, LTD. (KR) | 2006-05-18 | — | — | US | claimed |
| EP-1597632-A1 | NON-MAGNETIC MONOCOMPONENT POSITIVE TONER COMPOSITION HAVING SUPERIOR TRANSFER EFFICIENCY | LG Chem, Ltd. (KR) | 2005-11-23 | — | — | EP | claimed |
| WO-2004079456-A1 | NON-MAGNETIC MONOCOMPONENT POSITIVE TONER COMPOSITION HAVING SUPERIOR TRANSFER EFFICIENCY | LG CHEM, LTD. (KR) | 2004-09-16 | — | — | WO | claimed |
| US-6448343-B1 | CARBOXYLIC ACID ANHYDRIDE GRAFT OR COPOLYMER; REACTS WITH AN AMINOSILANE WHICH REACTS WITH FREE ACID ANHYDRIDE WHICH IN TURN REACTS WITH SECOND POLYMER; CREEP AND OIL RESISTANCE, TENSILE STRENGTH; ADHESIVES, SEALANTS, INSULATION | CROMPTON CORPORATION | 2002-09-10 | — | — | US | claimed |
| US-6191286-B1 | REACTING AN AMINO ALKYL DIALKOXYSILANE OR AMINO TRAIALKOXYSILANE AND UNSATURATED ACID ANHYDRIDE TO FORM AN AMICACID SILANE, TREATING AMICACID SILANE WITH A SILYLATING OR ESTERIFYING CAPPING AGENT, HEATING TO FORM IMIDOSILANE | OSI SPECIALTIES INC. | 2001-02-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140031289-A1 | POLY(ORGANOPHOSPHAZENE) CONTAINING DEGRADATION CONTROLLABLE IONIC GROUP, PREPARATION METHOD THEREOF AND USE THEREOF | PHOSPHO1, PLCB3, INPP5D | DHODH 2541/4885PARP1 3083/4885PARP15 3768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.